Wai-Loon, Calvin Ho

Ho Wai-Loon, Calvin

  • Assistant Professor, Centre for Biomedical Ethics
Administrative Appointment(s)
  • Deputy Director, Undergraduate Health Ethics, Law and Professionalism Curriculum, Centre for Biomedical Ethics
  • Member, Interprofessional Education Steering Committee, National University of Singapore
  • Member, Paediatric Ethics and Advocacy Centre, National University Hospital
Joint Appointment(s)
  • Advocate and Solicitor, Supreme Court of Singapore
  • Co-Head, Collaborating Centre for Bioethics of the World Health Organization
  • Assistant Director, Legal Aid Bureau, Ministry of Law
  • Co-Head, Accountability Policy Task Team, Global Alliance for Genomics & Health
  • Ethics Board Member, Médecins Sans Frontières (Doctors Without Borders)
  • Member, Medicines in Health Systems Thematic Working Group, Health Systems Global
  • Member, Singapore Nursing Board
  • Member, National Transplant Ethics Panel
  • Member, Bioethics Committee, Ng Teng Fong General Hospital
Academic Qualifications
  • JSD, Cornell University, USA
  • LLM, Cornell University, USA
  • MSc, SOAS University of London, United Kingdom
  • LLB (Hons), NUS/University of Cambridge, United Kingdom
  • BSc (Hons), London School of Economics and Political Science, University of London, United Kingdom
Research Interest(s)
  • Universal Health Coverage
  • Access to Medicines and Innovative Therapies
  • Research Governance
  • Public Health Surveillance
  • Standard and Quality of Care
  • Others
Recent Publications
  • 1. Chan TW, Ho WLC. 2017 Dec. A Ten-Year Retrospective Analysis of Consent for the Donation of Residual Human Tissue in a Singapore Healthcare Institution: Reflections on Governance. Asian Bioethics Review. 9(4):335-351. doi: 10.1007/s41649-017-0040-x.
  • 2. Lajaunie C, Ho WLC. 2017 Nov. Pathogens collections, biobanks and related-data in a One Health legal and ethical perspective. Parasitology. 1-8. doi: 10.1017/S0031182017001986.
  • 3. Coleman CH, Ho WLC. 2017 Jul. Selling pharmaceuticals ethically in resource-limited settings: The case of Sofosbuvir. Asian Bioethics Review. 9(1-2):87-101. doi: 10.1007/s41649-017-0014-z.
  • 4. Kaewkungwal J, Adams P, Sattabongkot J, Matsui K, Ho WLC, Wendler DS, Lie R. 2017 Jul. Enhancing research quality with updated and controversial ethical issues: Summary and recommendations. Asian Bioethics Review. 9(1-2):157-167. doi: 10.1007/s41649-017-0008-x.
  • 5. Ho WLC. 2017 Jul. CIOMS guidelines remain conservative about vulnerability and social justice. Indian J Med Ethics. 2(3):175-179. doi: 10.20529/IJME.2017.061.